Warehouse Robotics Startup Secures $85M in Funding

Warehouse robotics startup Mujin has raised $85 million in its latest funding round, to increase its U.S. market standing and boost the accessibility of its robotics MujinController platform.

The latest funding round was led by SBI Investments, with participation from Accenture, Pegasus Tech Ventures, 7 Industries and angel investor James Kuffner.

The round brings Mujin’s total outside funding to more than $150 million.

The Tokyo-based company said the funds will be used to expand the reach of MujinController, a platform designed to “transform” industrial robots into smart, automated machines by using, among other things, digital twin and AI technology. 

The MujinController works by attaching to a company’s existing robotic infrastructure, such as robotic arms and automates the process of programming the tools. The plug-and-play system offers a single software system for multiple robots, bypassing the need for specific configuration for each required task, and enabling significant savings on time and money.

“The MujinController introduces a unique approach to creating robotics applications, leveraging a real-time non-volatile digital twin and offering a suite of perception, planning, and control algorithms to digitize the real world and autonomously move robots and other industrial equipment through it,” said Ross Diankov, Mujin’s cofounder. “We are excited to continue our journey toward perfecting the MujinController and getting it into everyone’s hands.”

Related:Industrial Robotics Company Raises $4.1M

Mujin also has two warehouse robots of its own, QuickBot and TruckBot. The former automates the process of loading and unloading goods, while the latter is a robotic conveyor belt that unloads containers.

“Mujin has developed a platform technology that enables companies to develop and deploy automation solutions that were previously not possible,” said Anis Uzzaman, Pegasus CEO. “As a result, Mujin has been able to race ahead of the competition and deliver results that others cannot."